INTRODUCTION
Most pharmaceutical dosage forms for oral administration are formulated for direct ingestion, for chewing, for prior dispersion and/or dissolution in water; some of them are absorbed in mouth (sublingual or buccal tablets) (Birudaraj et al., 2005) . Elderly individuals have difficulty in swallowing when prescribed in conventional tablet and capsule form (Rajitha et al., 2009 , Chang et al., 2000 , Yeola et al., 2000 . The problem of swallowing is also evident in pediatrics, psychiatric as well as traveling patients who may not have ready access to water. The rapidly disintegrating tablet in mouth oro-dispersible tablets overcome all the above problems and thus offer an alternate form of oral medication, which provide patients with a more convenient means of taking their Addition of super disintegrating agent in the formulation is one of the approaches to formulate oral dispersible tablets. Orally disintegrating tablets contain wide variety of pharmaceutical active ingredients covering many therapeutic categories. The time for disintegration of orally disintegrating tablets are generally considered less than 1 minute (IP, 2007) . Orally disintegrating tablets are characterized by high porosity, low density and low hardness. When administered, an in-situ suspension is created in the oral cavity as the tablet disintegrates and is subsequently swallowed. Solid dosage forms are popular because of ease of administration, accurate dosage, self medication, pain avoidance and most importantly patient compliance (IP, 2007) . Keeping in view the advantages of this delivery system, in the present study attempts were made to formulate taste masked orally disintegrating tablets of ciprofloxacin which is used as an antibiotic taste masking of ciprofloxacin was done by keeping it with sodium saccharin and different superdisintegrating agent.
INTRODUCTION Materials
Ciprofloxacin was gifted from Dr. Reddy's Laboratories (Hyderabad, India). Crospovidone, sodium starch glycolate were obtained from Merck LTD (Mumbai). Magnesium stearate and all other ingredients used were of analytical grade.
Super Disintigrants
Crospovidone It is a white, free flowing, compressible powder; a synthetic homopolymer of cross-linked N-vinyl pyrrolidinone. It is completely insoluble in water, acids, alkalis and all organic solvents. Hygroscopic in nature, swells rapidly in water, rapidly disperse in water, but does not gel even after prolonged exposure (IP, 2007) . Sodium Starch Glycolate It is sodium salt of carboxymethyl ether of starch. It is white to off white tasteless, odourless, relatively free flowing powder, insoluble in organic solvent (IP, 2007) .
Preparation of fast disintegrating tablets of ciprofloxacin by Kneading technique
Required quantity of ciprofloxacin was weighed and sifted through # 40 ASTM SS sieve. Drug was mixed with the crospovidone and starch glycolate in different ration (Table 1) with the above powder base with sifted avicel, and other exicipients by tumbling. All the ingredients were mixed thoroughly for not less than 5 minutes and until to get uniform mixed powder. Finally, the lubricated granules were compressed on rotary tablet machine (Sastr et al., 2000; Ito et al., 1996; Dobetti, 2001 ).
Evaluation of granules
The angle of repose was measured by using funnel method (Kuchekar et al., 2003) which indicates the flow ability of the granules. Loose bulk density (LBD) and tapped bulk density (TBD) (Liberman and Lachman, 2006) were measured using the formula-LBD = TBD = Compressibility index (Shah and Rampadhan, 1997) of the granules was determined by using the formu-
Evaluation of the tablets All prepared matrix tablets were evaluated for its uniformity of weight, hardness, friability and thickness according to official methods (Aulton and Well, 2000) .
Hardness
The crushing strength of the tablets was measured using a Monsanto hardness tester. Three tablets from each formulation batch were tested randomly and the average reading noted.
Friability
Ten tablets were weighed and placed in a Roche friabilator (Electrolab USP friabilator) and the equipment was rotated at 25 rpm for 4 min. The tablets were taken out, dedusted and reweighed. The percentage friability of the tablets was calculated as per the following formula-
Percentage friability = Initial weight -Final weight
Initial weight × 100
Weight Variation
Randomly, twenty tablets were selected after compression and the mean weight was determined. None of the tablets deviated from the average weight by more than ±7.5% (USP XX).
Drug content
Twenty tablets were weighed and powdered by using mortar and pestle. An amount of the powder equivalent to 150 mg of ciprofloxacin was dissolved in 100ml of phosphate buffer pH 6.8, filtered, diluted suitably and analyzed for drug content at 257nm using UV-Visible spectrophotometer (UV 160 Shimadzu, Japan).
Wetting time
A piece of tissue paper (12cmX10.75cm) folded twice was placed in a Petri dish (Internal Diameter=9cm) containing 9ml of buffer solution simulating saliva pH 7.4, which had the following composition, NaCl (0.126g), KCl (0.964g), KSCN (0.189g), KH2PO4 (0.655g) and urea (0.200g) in 1Litre of distilled water. A tablet was placed on the paper and the time taken for complete wetting was noted. Three tablets from each formulation were randomly selected and the average wetting time was noted.
Water absorption ratio (R)
The weight of the tablet prior to placement in the petri dish was noted (wb) utilizing a Shimadzu digital balance. The wetted tablet was removed and reweighed (wa). Water absorption ratio, R, was then determined according to the following equation.
Here wb and wa were tablet weights before and after water absorption, respectively.
In Vitro dispersion time
In vitro Dispersion time was measured by dropping a tablet in 10ml measuring cylinder containing 6ml of 0.1N hydrochloric acid.
In Vitro disintegration time 10 ml of water at 25°C was placed in a petri dish of 10 cm diameter. The tablet was then carefully positioned in the center of the petri dish and the time required for the tablet to completely disintegrate into fine particles was noted.
In Vitro drug release studies
In vitro drug release studies of all the formulations were carried out using tablet dissolution test apparatus (USP XXII type II Labindia, Mumbai, India) at 50 rpm. Phosphate buffer pH 6.8 was used as the dissolution media with temperature maintained at 37±1°C. Samples were withdrawn at different intervals, diluted suitably and analyzed at 257 nm for cumulative drug release using an ultraviolet visible spectrophotometer (Shimadzu 1700 series). The study was performed in triplicate.
Stability studies
Short term stability studies on the optimum formu- lation (F-2, F-5) were carried out by storing the tablets (in amber colored rubber stoppered vials) at 40°C/75% RH for 3 weeks. At every 1 week intervals, the tablets were examined for physical changes, properties, drug content and in vitro release studies Robinson, 2006, Marshall et al., 2000) .
RESULTS AND DISCUSSION
The supplied drug passed the various tests of identification and analysis. The pure drug ciprofloxacin and the solid admixture of drug and various excipients used in the preparation of fast dispersible tablet formulations were characterized by FT-IR spectroscopy to know the compatibility (Figure 1 ).
The FT-IR study did not show any possibility of interaction between ciprofloxacin and superdisintegrants used in the fast dispersible tablets.
Since the flow properties of the powder mixture are important for the uniformity of the mass of the tablets, the flow of the powder mixture was analyzed before compression of the tablets. The results of angle of repose and compressibility index (%) ranged from (23.33±0.11 to 28.99±0.33) and (13.23±38 to 15.21±19), respectively. The loose bulk density and tapped bulk density were ranged from (0.278±0.20 to 0.521±0.3) and (0.346±0.17 to 0.589±0.24), respectively. The lowest compressibility index is 5-15 % which indicates excellent flow properties ( Table 2 ).
The physical properties of different batches of fast dissolving tablets are given in table 3. Tablet mean thickness was almost uniform in all the formulations. The thickness varies between 2.01±0.18 to 2.51±1.72 mm. The prepared tablets in all the formulations possessed good mechanical strength with sufficient hardness in the range of 3.03±1.19 to 3.81±1.8 kg/sq.cm. Friability values below 1% were an indication of good mechanical resistance of the tablets. The weight variation in all the six formulations was found to be 199.71 to 202.19 mg, thus the tablets from each formulation passed weight variation test, as the % weight variation was within the pharmacopoeial limits of ±7.5% of the weight. The percentage drug content of all the tablets was found to be between 96.56±0.22 to 99.1±0.08 % of Ciprofloxacin which was within the acceptable limits. 
The wetting time for all the six formulations was performed in triplicate. The values lie between 23 to52 sec. In vitro dispersion is a special parameter in which the time taken by the tablet to produce complete dispersion is measured. The time for all the six formulations varied between 30 to 45 sec. Tablets were prepared with crospovidone F-1 to F-3 and with SSG F-4 to F-6. The wetting time, in vitro dispersion time of the tablets were also considerably reduced in tablets containing crospovidone which may be attributed due to the wicking type of disintegrants (crospovidone) formed thus facilitating the disintegrants to bring about faster disintegration. The water absorption ratio (%) and in vitro disintegrating time (sec) were ranged from (91 to 97) and (36 to 41), respectively. The in vitro dissolution profile indicated faster and maximum drug release from formulation F-2 & F-5 (Figure 2) . In vitro drug release results of all the formulations were satisfactory (Figure 3) . Stability studies showed no significant change when compared with zero day of formulation (F-2 & F-5). The disintegration times of tablets prepared with crospovidone were comparatively lower than that with sodium starch glycolate (Figure 3) . The faster disintegration of these tablets may be attributed to the rapid capillary activity and pronounced hydration of crospovidone with little tendency to gel formation. Thus, these results suggest that the disintegration time can be decreased by using wicking type of disintegrants (crospovidone).
CONCLUSION
The oral disintegrating tablets of ciprofloxacin with sufficient mechanical strength, acceptable taste and smaller disintegration time were achieved employing suitable superdisintegrants and other excipients at optimum concentration. Stability studies revealed that there was no significant change in drug content and dissolution profile of oral disintegrating tablets. FTIR studies revealed that there was no shift in peaks, indicating there is no interaction between ciprofloxacin and other ingredients used. Among two superdisintegrants used, crospovidone showed better performance in disintegration time when compared to sodium starch glycolate. So the formulation of F-2 was found to be best among all other formulations, because it has exhibited faster wetting time, good taste and faster disintegration time when compared to all other formulations. 
